Peter Libby
Impact in
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases
- Immune Response and Inflammation
Papers in
- Pharmacology 11
- Inflammatory mediators and NSAID effects 11
-
- Inflammasome and immune disorders 2
- Co-authors
- Gary B. Friedman (1 shared paper)Stephen J. Warner (1 shared paper)Galina K. Sukhova (4 shared papers)Richard T. Lee (1 shared paper)Zorina S. Galis (1 shared paper)Kiyoshi Takayama (2 shared papers)Jason Comander (1 shared paper)Michael A. Gimbrone (1 shared paper)
- Journals
- Journal of the American College of Cardiology (2 papers)Journal of Cardiovascular Pharmacology (2 papers)Thrombosis and Haemostasis (1 paper)JACC Basic to Translational Science (1 paper)Journal of Lipid Research (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Peter Libby
22 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 105
- Pharmacology 410
- Immunology 459
- Biochemistry 151
- Immunology and Allergy 107
- Cardiology and Cardiovascular Medicine 289
Countries citing papers authored by Peter Libby
This map shows the geographic impact of Peter Libby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Libby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Libby more than expected).
Fields of papers citing papers by Peter Libby
This network shows the impact of papers produced by Peter Libby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Libby. The network helps show where Peter Libby may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Libby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 471 | |
| 2 | 1995 | 326 | |
| 3 | 2002 | 296 | |
| 4 | 2009 | 94 | |
| 5 | 2017 | 88 | |
| 6 | 1975 | 78 | |
| 7 | 2011 | 71 | |
| 8 | 2006 | 61 | |
| 9 | 2016 | 48 | |
| 10 | 2017 | 39 | |
| 11 | 2018 | 38 | |
| 12 | 2018 | 31 | |
| 13 | 2014 | 26 | |
| 14 | 2015 | 23 | |
| 15 | 2024 | 14 | |
| 16 | 1999 | 13 | |
| 17 | 2024 | 8 | |
| 18 | 2018 | 6 | |
| 19 | 2024 | 4 | |
| 20 | 2025 | 4 |
About Peter Libby
Peter Libby is a scholar working on Pharmacology, Molecular Biology, Immunology, Surgery and Cardiology and Cardiovascular Medicine, having authored 22 papers that have together received 1.7k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (11 papers), Chemokine receptors and signaling (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), NF-κB Signaling Pathways (2 papers), Inflammasome and immune disorders (2 papers), Cell Adhesion Molecules Research (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). The work is most often cited by research in Pharmacology (410 citations), Immunology (459 citations), Biochemistry (151 citations), Immunology and Allergy (107 citations) and Cardiology and Cardiovascular Medicine (289 citations). Peter Libby has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Gary B. Friedman, Stephen J. Warner, Galina K. Sukhova, Richard T. Lee, Zorina S. Galis, Kiyoshi Takayama, Jason Comander, Michael A. Gimbrone, Guillermo García‐Cardeña and Eva H.C. Tang. Their work appears in journals such as Journal of the American College of Cardiology, Journal of Cardiovascular Pharmacology, Thrombosis and Haemostasis, JACC Basic to Translational Science and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.